| 16:00 | Welcome Moderator: Irem Ates, Senior Account Manager, ZN ConsultingHypermoderator: Luiza Fundatureanu, Account Manager, ZN Consulting
 | 
| 16:05 | Welcome and setting the scene Piera Polidori, Director of the Clinical Pharmacy Department, Mediterranean Institute for Transplantation and Advanced Specialized Therapies & Director of Professional Development, European Association of Hospital Pharmacists | 
| Prospective risk assessments | 
| 16:10 | Prospective risk assessments: A European perspective Nenad Miljković, Head of Hospital Pharmacy Services, Institute of Orthopaedic Surgery “Banjica” & Director of Finance, European Association of Hospital Pharmacists | 
| 16:20 | Prospective risk assessments: An international perspective Brian Godman, Visiting Professor, University of Strathclyde, Strathclyde Institute of Pharmacy and Biomedical Sciences | 
| Prevention and response plans | 
| 16:30 | The patient perspective on prevention and management plans in France Charlotte Roffiaen, EU Advocacy Advisor, France Assos Santé | 
| 16:37 | The hospital pharmacy perspective on prevention and management plans in France Serri Traoré, Hospital Pharmacist, Ramsay Santé Hôpital prive La Louvière | 
| The potential of prospective risk assessments and prevention/response plans for mitigating shortages | 
| 16:45 | European Parliament perspective TBC | 
| 16:50 | European Commission perspective TBC | 
| 16:55 | Q&A | 
| 17:05 | Closing remarks Svens Henkuzens (Director at State Agency of Medicines of Latvia, Member of the Management Board of the European Medicines Agency & Member of Heads of Medicines Agencies Management Group) | 
| 17:10 | Wrap up Piera Polidori, Director of the Clinical Pharmacy Department, Mediterranean Institute for Transplantation and Advanced Specialized Therapies & Director of Professional Development, European Association of Hospital PharmacistsModerator: Irem Ates, Senior Account Manager, ZN Consulting
 |